GE Aerospace filed its Q1 2026 10-Q on April 21, 2026. The headline — LEAP engine deliveries +63% YoY to 520 units, shop visits +35%, total RPO $211B — reads as consensus confirmation at a $380B large-cap. The useful finding isn't the print itself. It's what the cross-supplier data says about which node in the aerospace supply chain actually unlocked, and whether the market has correctly distinguished it.

What the filing says

• LEAP deliveries: 520 vs 319 Q1 2025 (+63%). Prior guidance language: "continue to improve quarter over quarter." This was a step-function, not a ramp.
• Management explicitly cited "improved material supply" as the driver.
• Internal shop visit revenue growth: +35% YoY, accelerated from +11% in Q1 2025 — tripled into the Middle East headwind the market was pricing as deceleration.
• Total RPO +$20.7B in one quarter to $211,299M. CES services RPO $171,376M; 17.5 years of revenue visibility.
• CES segment profit margin 26.4% vs 28.7% (−230 bps), attributed to "higher install engine deliveries" — standard LEAP install-loss mechanics.
• New language: "impacts [from Middle East] may include lower volume related to shop visits, spare parts and spare engines." First appearance in a GE quarterly. March MEA departures already declining.
• IEEPA tariffs struck by SCOTUS: $118M Q1 2025 charge reversed; GE "has not recorded a benefit for potential refunds."
• Defense (DPT) segment RPO +16% in one quarter to $30,027M.

What the market thinks

CRS options as of Apr 21: OI put/call 2.70, OTM put skew +32.8%, max pain $420 (−7%). Institutional money is hedging gains, not pressing. Smart flow reads as distributional.

Why the gap exists — and how small it is

Cross-supplier corroboration: Safran (CFM JV partner) ran 1,800 LEAP FY2025 (+28%). Carpenter Technology specialty alloy orders +30% sequential in Q4 2025 — the direct Q1 2026 catalyst GE didn't have to name. Hexcel LEAP composite deliveries exceeded pre-pandemic 2019 peak. Howmet guided +15% — muted.

The constraint that cleared was alloys and composites, not castings. Yet HWM trades +114% 1Y on the generic "aerospace supply chain" narrative alongside the unlocking nodes. The market hasn't cleanly distinguished between the suppliers that drove the LEAP ramp (CRS, HXL) and the ones that are simply beneficiaries of general aerospace demand (HWM).

That's the bifurcation. It's also mostly priced. CRS is +170% 1Y at 52× earnings with RSI 78 and institutional hedging. The fat pitch was at $167, not $452. The forward edge now lives at the supplier earnings reports in April-May 2026, where the bifurcation will be adjudicated by primary-source data.

Risks (ranked)

1. MEA aviation impact materializes in GE Q2 print (Hormuz blockade Day 44+). Shop visit growth drops to 15-20%, aftermarket narrative inverts. Factor scenario "reverses" state.
2. Q4 2025 supplier order surge was catch-up, not structural. CRS/HXL Q1 reports print in-line; high-multiple names sell off on "good but not great."
3. LEAP durability reserves (Note 14 in GE 10-Q, unquantified) signal systematic component issues at higher cycle counts. Warranty liability without volume offset.
4. Boeing 737 MAX production rate cut. Removes LEAP pull regardless of supplier readiness.
5. Supplier momentum unwind. +100%+ 1Y names are vulnerable to broad risk-off rotation unrelated to fundamentals.

Catalysts

• HXL Q1 2026 earnings: ~late April 2026 (verifies composite trajectory)
• HWM Q1 2026 earnings: ~late April-early May 2026 (tests "muted" thesis)
• CRS Q3 FY26 earnings: ~early May 2026 (primary bifurcation test)
• Safran H1 2026 results: July 2026 (industry-wide LEAP confirmation)
• GE Q2 2026 earnings: ~late July 2026 (first MEA-affected quarter)

What would change our mind

• CRS next print: aerospace & defense book-to-bill <1.2x, or alloy revenue growth below +25% YoY → Q4 2025 was one-off, bifurcation thesis weakens.
• HWM reports engine-castings mix growing +25-30% — casting/alloy distinction less durable than filing cross-check implied.
• GE Q2 shop visit growth below +20% — MEA disruption overwhelms supply unlock; factor scenario "reverses" state validated.
• Safran FY2026 LEAP guide cut — industry-wide ramp stalls.
• Boeing 737 MAX production rate below 42/month — LEAP pull declines.

Evidence